The present invention is directed to aminomethyl compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the beta-secretase enzyme is involved, such as Alzheimers disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the treatment of such diseases in which the beta-secretase enzyme is involved.La présente invention concerne des composés daminométhyle qui sont des inhibiteurs de lenzyme β-secrétase et qui sont utilisés dans le traitement de maladies, dans lesquelles est impliquée ladite enzyme β-secrétase, telles que la maladie dAlzheimer. Cette invention a aussi pour objet des compositions pharmaceutiques renfermant ces composés et lutilisation desdits composés et compositions dans le traitement de maladies, dans lesquelles est impliquée lenzyme β-secrétase.
